Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization

INTRODUCTION: Chemokine (C-C motif) ligand 18 (CCL-18) has been shown to be elevated in chronic obstructive pulmonary disease (COPD) patients. This study primarily aimed to evaluate whether the serum CCL-18 level differentiates the frequent exacerbator COPD phenotype from infrequent exacerbators. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dilektasli, Asli Gorek, Demirdogen Cetinoglu, Ezgi, Uzaslan, Esra, Budak, Ferah, Coskun, Funda, Ursavas, Ahmet, Ercan, Ilker, Ege, Ercument
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221541/
https://www.ncbi.nlm.nih.gov/pubmed/28115842
http://dx.doi.org/10.2147/COPD.S118424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221541/
https://www.ncbi.nlm.nih.gov/pubmed/28115842
http://dx.doi.org/10.2147/COPD.S118424

Ejemplares similares